Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 9, 2006, Pages 1281-1287

  Yang, Hua ^a   Pang, Ji Yan ^b   Cai, Yu Chen ^a   Xu, Zun Le ^b   Xian, Li Jian ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZOFURAN DERIVATIVE; COLCHICINE; TUBULIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; MICROTUBULE ASSEMBLY; MITOSIS;

ANTINEOPLASTIC AGENTS; BENZOFURANS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITORY CONCENTRATION 50; MICROTUBULES; MITOSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; TUBULIN MODULATORS;

EID: 33748310931     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.9.0016     Document Type: Article

References (22)

1. Apers, S., Paper, D., Burgermeister, J., Baronikova, S., Van Dyck, S., Lemiere, G., Vlietinck, A., Pieters, L. (2002) Antiangiogenic activity of synthetic dihydrobenzofuran lignans. J. Nat. Prod. 65: 718-720
2. Bohnenstengel, F. I., Steube, K. G., Meyer, C., Quentmeier, H., Nugroho, B. W., Proksch, P. (1999) 1H-cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines. Z. Naturforsch. [C] 54: 1075-1083
3. Cho, J. Y., Kim, A. R., Yoo, E. S., Baik, K. U., Park, M. H. (1999) Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-alpha and nitric oxide production, and lymphocyte proliferation. J. Pharm. Pharmacol. 51: 1267-1273
4. Halabalaki, M., Aligiannis, N., Papoutsi, Z., Mitakou, S., Moutsatsou, P., Sekeris, C., Skaltsounis, A. L. (2000) Three new arylobenzofurans from Onobrychis ebenoides and evaluation of their binding affinity for the estrogen receptor. J. Nat. Prod. 63: 1672-1674
5. Hayakawa, I., Shioya, R., Agatsuma, T., Furukawa, H., Naruto, S., Sugano, Y. (2004) A library synthesis of 4-hydroxy-3-methyl-6-phenylbenzofuran-2- carboxylic acid ethyl ester derivatives as anti-tumor agents. Bioorg. Med. Chem. Lett. 14: 4383-4387
6. Hirano, T., Gotoh, M., Oka, K. (1994) Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci. 55: 1061-1069
7. Kangas, L., Saarinen, N., Mutanen, M., Ahotupa, M., Hirsinummi, R., Unkila, M., Perala, M., Soininen, P., Laatikainen, R., Korte, H., Santti, R. (2002) Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce. Eur. J. Cancer Prev. 11 (Suppl.): S48-S57
8. Li, Q. L., Li, B. G., Qi, H. Y., Gao, X. P., Zhang, G. L. (2005) Four new benzofurans from seeds of Styrax perkinsiae. Planta Med. 71: 847-851
9. Ma, Y., Han, G. Q., Wang, Y. Y. (1993) PAF antagonistic benzofuran neolignans from Piper kadsura. Yao Xue Xue Bao 28: 370-373
10. Maeda, S., Masuda, H., Tokoroyama, T. (1994) Studies on the preparation of bioactive lignans of oxidative coupling reaction. I. Preparation and lipid peroxidation inhibitory effect of benzofuran lignans related to schizotenuins. Chem. Pharm. Bull. (Tokyo) 42: 2500-2505
11. Musacchio, A., Hardwick, K. G. (2002) The spindle checkpoint: structural insights into dynamic signalling. Nat. Rev. Mol. Cell Biol. 3: 731-741
12. Pang, J. Y., Wang, B., Chen, Z. P., Xu, Z. L. (2005) Synthesis of 2-arylbenzo[b]furan derivatives. Chin. J. Org. Chem. 25: 176-181
13. Pauletti, P. M., Araujo, A. R., Young, M. C., Giesbrecht, A. M., Bolzani, V. D. (2000) nor-Lignans from the leaves of Styrax ferrugineus (Styracaceae) with antibacterial and antifungal activity. Phytochemistry 55: 597-601
14. Paulovich, A. G., Toczyski, D. P., Hartwell, L. H. (1997) When checkpoints fail. Cell 88: 315-321
15. Piccinelli, A. L., Mahmood, N., Mora, G., Poveda, L., De Simone, F., Rastrelli, L. (2005) Anti-HIV activity of dibenzylbutyrolactone-type lignans from Phenax species endemic in Costa Rica. J. Pharm. Pharmacol. 57: 1109-1115
16. Rowinsky, E. K., Donehower, R. C. (1991) The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther. 52: 35-84
17. Singleton, P., Sainsbury, D. (1987) Dictionary of microbiology and molecular biology. 2nd Edn, Wiley, New York
18. Stewart, Z. A., Westfall, M. D., Pietenpol, J. A. (2003) Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol. Sci. 24: 139-145
19. Tsai, I. L., Hsieh, C. F., Duh, C. Y. (1996) Additional cytotoxic neolignans from Persea obovatifolia. Phytochemistry 43: 1261-1263
20. Wang, J. P., Ho, T. F., Chang, L. C., Chen, C. C. (1995) Antiinflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice. J. Pharm. Pharmacol. 47: 857-860
21. Yang, Z., Liu, H. B., Lee, C. M., Chang, H. M., Wong, H. N. C. (1992) Regioselective introduction of carbon-3 substituents to 5-alkyl-7-methoxy-2- phenylbenzo[b]furans: synthesis of a novel adenosine A1 receptor ligand and its derivatives. J. Org. Chem. 57: 7248-7257
22. Yu, Y. U., Kang, S. Y., Park, H. Y., Sung, S. H., Lee, E. J., Kim, S. Y., Kim, Y. C. (2000) Antioxidant lignans from Machilus thunbergii protect CC14-injured primary cultures of rat hepatocytes. J. Pharm. Pharmacol. 52: 1163-1169